Страна;Наименование;Патент №;Дата;Срок действия

Австралия;«Codon-optimized recombinant plasmid, method of stimulating peripheral nerve regeneration, and method of treating nerve damage in humans»;AU2015390821;27.08.2015;05.04.2037 Австралия;«Optimized nucleotide sequence and pharmaceutical composition based thereon with prolonged VEGF transgene expression»;AU2015396177;07.12.2015;02.11.2037 Бразилия;«Method for creating a personalized gene-activated implant for regenerating bonetissue»;BR112016027050-9;13.10.2015;12.11.2039 Бразилия;«Optimized nucleotide sequence and pharmaceutical composition based thereon with prolonged VEGF transgene expression»;BR112017023058-5;07.12.2015;07.12.2035 Бразилия;«A pharmaceutical composition comprising for stimulation of angiogenesis»;BR112015002522-6;02.08.2015;07.11.2037 Бразилия;"Codon-optimized recombinant plasmid, containing VEGF and FGF2-coding genes, for use in peripheral nerve regeneration";BR112017005310-1;27.08.2015;14.02.2038 ЕС;«Biocomposite for regeneration of injured tissue and organs, a kit for making the biocomposite, method of making the biocomposite and a method of treatinginjuries»;2797633;24.12.2012;05.11.2034 ЕС;«A pharmaceutical composition comprising for stimulation of angiogenesis»;2890777;02.08.2013;31.07.2037 ЕС;«Codon-optimized recombinant plasmid, method of stimulating peripheral nerve regeneration, and method of treating nerve damage in humans»;3196307;27.08.2015;26.07.2037 ЕС;«Method for creating a personalized gene-activated implant for regenerating bone tissue»;3130342;13.10.2015;15.02.2037 ЕС;«Optimized nucleotide sequence and pharmaceutical composition based thereon with prolonged VEGF transgene expression»;3305901;07.12.2015;11.04.2038 Индия;«A pharmaceutical composition comprising for stimulation of angiogenesis»;329291;28.01.2015;01.07.2036 Индия;«Optimized nucleotide sequence and pharmaceutical composition based thereon with prolonged VEGF transgene expression»;467304 (201717039297);03.11.2017;11.03.2037 Индонезия;«A pharmaceutical composition comprising for stimulation of angiogenesis»;ID000052722;02.08.2013;16.08.2038 Канада;«Biocomposite for regeneration of injured tissue and organs, a kit for making the biocomposite, method of making the biocomposite and a method of treatinginjuries»;2866483;24.12.2012;04.07.2033 Канада;«A pharmaceutical composition comprising for stimulation of angiogenesis»;2881799;02.08.2013;06.03.2034 Канада;«Codon-optimized recombinant plasmid, method of stimulating peripheral nerve regeneration, and method of treating nerve damage in humans»;2960371;27.08.2015;13.10.2036 Канада;«Method for creating a personalized gene-activated implant for regenerating bonetissue»;2946389;13.10.2015;18.08.2036 Канада;«Optimized nucleotide sequence and pharmaceutical composition based thereon with prolonged VEGF transgene expression»;2985608;07.12.2015;01.12.2036 Китай;«A pharmaceutical composition comprising for stimulation of angiogenesis»;105308173;02.08.2013;03.02.2036 Китай;«Method for creating a personalized gene-activated implant for regenerating bonetissue»;106488771;13.10.2015;08.03.2037 Китай;«Optimized nucleotide sequence and pharmaceutical composition based thereon with prolonged VEGF transgene expression»;107614687;07.12.2015;19.01.2038 Китай;«Optimized nucleotide sequence and pharmaceutical composition based thereon with prolonged VEGF transgene expression»;201717039297 (№467304);03.11.2017;03.11.2037 Мексика;«A pharmaceutical composition comprising for stimulation of angiogenesis»;360980;27.02.2015;02.08.2033 Мексика;«Optimized nucleotide sequence and pharmaceutical composition based thereon with prolonged VEGF transgene expression»;MX403135B;26.05.2015;07.12.2035 Мексика;«Method for creating a personalized gene-activated implant for regenerating bone tissue»;375413;13.10.2015;13.10.2035 Мексика;«Codon-optimized recombinant plasmid, method of stimulating peripheral nerve regeneration, and method of treating nerve damage in humans»;385916;;27.08.2035 США;«Biocomposite for regeneration of injured tissue and organs, a kit for making the biocomposite, method of making the biocomposite and a method of treating injuries»;9730959;24.12.2012;20.11.2034 США;«A pharmaceutical composition comprising for stimulation of angiogenesis»;9616103;08.02.2013;26.11.2035 США;«Nucleotide sequence and pharmaceutical composition based thereon with prolonged VEGF transgene expression»;9896493;15.03.2016;01.12.2036 США;«Method for creating a personalized gene-activated implant for regenerating bonetissue»;11406739;06.07.2017;27.07.2037 США;«Codon-optimized recombinant plasmid, method of stimulating peripheral nerve regeneration, and method of treating nerve damage in humans»;10434145;18.07.2017;09.11.2037 США;«Nucleotide sequence and pharmaceutical composition based thereon with prolonged VEGF transgene expression»;10040837;21.11.2017;29.03.2038 Украина;«Biocomposite for regeneration of injured tissue and organs, a kit for making the biocomposite, method of making the biocomposite and a method of treating injuries»;112450;;12.09.2036 ЮАР;«A pharmaceutical composition comprising for stimulation of angiogenesis»;2015/00909;31.08.2012;26.10.2036 Япония;«Codon-optimized recombinant plasmid, method of stimulating peripheral nerve regeneration, and method of treating nerve damage in humans»;6540797;27.08.2015;01.11.2037 Япония;«Method for creating a personalized gene-activated implant for regenerating bone tissue»;6631924;13.10.2015;01.03.2038